Evidence Hub

Head trauma complicated with multi-site infections of Ureaplasma urealyticum and Mycoplasma hominis: a case report

Bai X, Sang Y, Ke L, Chen M, Su N, Li S, Hong X, Xie S et al.

BMC infectious diseases, 2025

Abstract

BACKGROUND: Mycoplasma hominis and Ureaplasma urealyticum are genitourinary colonizers that can cause extragenital infection after trauma or surgery, yet diagnosis is frequently delayed by negative routine cultures. CASE PRESENTATION: A 60-year-old man developed persistent postoperative infection after decompressive craniotomy for head trauma. Routine cultures were non-informative. Guided by a stepwise protocol (targeted sampling of blood/cerebrospinal fluid (CSF)/wound and urethral reservoir), we detected M. hominis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)/culture and confirmed disseminated U. urealyticum by species-specific qPCR (multiple sites except CSF). Targeted therapy (doxycycline with levofloxacin) led to clinical resolution. CONCLUSIONS: In ICU trauma or postoperative patients with culture-negative infection despite β-lactams, targeted testing for mollicutes, combining mycoplasma and ureaplasma culture, MALDI-TOF MS, and species-specific qPCR, can expedite diagnosis and guide effective therapy. CLINICAL TRIAL NUMBER: Not applicable.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free